BCTX NASDAQ
BriaCell Therapeutics Corp.
1W: -6.5%
1M: +13.2%
3M: +15.4%
YTD: -43.6%
1Y: -67.9%
3Y: -99.6%
5Y: -99.1%
$4.04
-0.07 (-1.70%)
Weekly Expected Move ±10.9%
$3
$4
$4
$4
$5
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$30M
+265.1% ▲
5Y CAGR: +124.5%
Total Liabilities
$6M
-50.1% ▼
5Y CAGR: +7.6%
Shareholders Equity
$25M
+843.3% ▲
Cash & Investments
$25M
+1952.6% ▲
5Y CAGR: +309.8%
Total Debt
$0
+0.0% ▲
Net Debt
-$14M
-1105.6% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $72M | $53M | $28M | $1M | $14M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $10M |
| Cash & ST Investments | $72M | $53M | $28M | $1M | $25M |
| Net Receivables | $16K | $31K | $959K | $2M | $777K |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $72M | $54M | $36M | $5M | $27M |
| Property, Plant & Equip. | $0 | $0 | $0 | $539K | $408K |
| Goodwill & Intangibles | $307K | $295K | $287K | $277K | $254K |
| Long-Term Investments | $0 | $0 | $0 | $581K | $721K |
| Other Non-Current Assets | $0 | $0 | $0 | $2M | $987K |
| Total Non-Current Assets | $307K | $295K | $287K | $3M | $2M |
| Total Assets | $73M | $55M | $36M | $8M | $30M |
| — Liabilities — | |||||
| Accounts Payable | $268K | $594K | $2M | $10M | $5M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $0 | $0 | $955K |
| Total Current Liabilities | $696K | $1M | $2M | $10M | $5M |
| Long-Term Debt | $32K | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $37M | $40M | $39M | $2M | $464K |
| Total Non-Current Liabilities | $37M | $40M | $39M | $2M | $464K |
| Total Liabilities | $38M | $41M | $41M | $12M | $6M |
| — Equity — | |||||
| Common Stock | $68M | $84M | $93M | $100M | $140M |
| Retained Earnings | -$36M | -$77M | -$108M | -$119M | -$154M |
| Accumulated OCI | -$173K | -$178K | -$185K | -$193K | $38M |
| Total Stockholders Equity | $35M | $13M | -$5M | -$3M | $25M |
| Total Liabilities & Equity | $73M | $55M | $36M | $8M | $30M |
| — Key Metrics — | |||||
| Total Debt | $32K | $0 | $0 | $0 | $0 |
| Net Debt | -$72M | -$53M | -$28M | -$1M | -$14M |
| Total Investments | $0 | $0 | $0 | $581K | $11M |